Verdence Capital Advisors’s Zivo Bioscience, Inc. Common Stock ZIVO Stock Holding History

Verdence Capital Advisors’s Portfolio ZIVO Stock Details ZIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,667	Closed	-$13K	–	605
2023 Q3	$13K	Hold	1,667	–	–	﹤0.01%	557
2023 Q2	$24.2K	Hold	1,667	–	–	﹤0.01%	531
2023 Q1	$30.8K	Hold	1,667	–	–	﹤0.01%	532
2022 Q4	$25K	Hold	1,667	–	–	﹤0.01%	492
2022 Q3	$28K	Hold	1,667	–	–	﹤0.01%	513
2022 Q2	$39K	Hold	1,667	–	–	0.01%	506
2022 Q1	$39K	Hold	1,667	–	–	﹤0.01%	507
2021 Q4	$29K	Hold	1,667	–	–	﹤0.01%	502
2021 Q3	$46K	Buy	+1,667	New	+$36.5K	0.01%	489

Other funds holding ZIVO

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.82B AUM 15.4% 1-Year Est. Return

Verdence Capital Advisors's ZIVO Position: Q4 2023 in Review

Verdence Capital Advisors sold out of Zivo Bioscience, Inc. Common Stock (ZIVO) in Q4 2023, closing a stake of 1,667 shares — an estimated $13K sold.

Verdence Capital Advisors first reported a position in ZIVO in Q3 2021 and held it in 9 quarters. The position peaked at $46K in Q3 2021. 2 funds tracked by Wall St. Rank hold ZIVO as of Q4 2023.

Verdence Capital Advisors reported no remaining Zivo Bioscience, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Verdence Capital Advisors sold 1,667 Zivo Bioscience, Inc. Common Stock shares in Q4 2023, an estimated $13K.
Verdence Capital Advisors first reported a position in Zivo Bioscience, Inc. Common Stock in Q3 2021 and held it in 9 quarters.
Verdence Capital Advisors's Zivo Bioscience, Inc. Common Stock position peaked at $46K in Q3 2021.
2 funds tracked by Wall St. Rank held Zivo Bioscience, Inc. Common Stock as of Q4 2023.

Based on Verdence Capital Advisors's 13F filing for Q4 2023, filed 1 Feb 2024.